LABOMAR CANADA
About LABOMAR CANADA
We are committed to contributing to society's better health.Established in 1990 in Montreal, Canada, we are a pharmaceutical company with more than 30 years' experience in the manufacturing of semi-solid (creams, ointments, gels, lotions) and liquid products. Our core business area is the development, production and packaging of top-quality products for the pharmaceutical, cosmetic and nutraceutical industry. The Company became part of the Labomar Group in 2019 and in 2023 changes its business name to Labomar Canada.
Our mission is to provide customer-driven manufacturing services of the highest quality with products that will meet and exceed current and evolving client's expectations. Our objective is to maintain our position as a reliable reference point in the manufacturing of quality pharmaceutical products: essentially, a benchmark for modern, efficient production, assured through the use of highly performing equipment.Labomar Canada offers manufacturing capabilities ranging from laboratory to pilot batches to scale-ups. The facilities are approved and inspected by Health Canada and FDA and registered under accredited GMP pharmaceutical standards.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $10M to $50M
- Total Funding: None None
- Last Funding: None None (None)
- Funding Status: None
Technology Stack
LABOMAR CANADA actively uses None products in their tech stack.
Market Presence
Industries: Pharmaceuticals, Pharmacuetical contract manufacturing & packaging, Semisolids & liquids, Highend cosmetics, Fabrication et emballage en soustraitance de produits pharmaceutiques
Headquarters: Pointe-Claire, Quebec